RevieweGastroenterology2024

Drug-target Mendelian randomisation applied to metabolic dysfunction-associated steatotic liver disease: opportunities and challenges.

Shan Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.